ReviewInternational microbiology : the official journal of the Spanish Society for Microbiology2026
Exopolysaccharides from lactic acid bacteria: functional ingredients with biotechnological potential - a critical review.
Review in International microbiology : the official journal of the Spanish Society for Microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Antioxidant capacity, and probiotic properties of Enterococcus faecium strains isolated from raw milk of indigenous brown atlas cows.Antonie van Leeuwenhoek · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Exopolysaccharides (EPS) produced by lactic acid bacteria (LAB) hold significant potential across multiple industries, with applications extending from food technology to pharmaceuticals. Although numerous studies have explored their technological and biological functionalities such as thickening, stabilization, and health-promoting effects the existing literature remains fragmented regarding the biosynthesis mechanisms, genetic regulation, and structure function relationships of LAB-derived EPS. Moreover, current reviews often address these aspects separately, lacking an integrated perspective that connects molecular mechanisms to practical applications. This review fills these gaps by providing a comprehensive and unified analysis of LAB produced EPS, covering their classification, biosynthetic pathways (including the influence of genetic determinants), structural diversity, technological roles, and biological activities. It also evaluates recent advances in production optimization and analytical characterization techniques. By consolidating dispersed knowledge, this review offers a holistic framework that links molecular insights with functional outcomes, thus supporting the rational design of LAB strains for targeted EPS production. The focus on LAB EPS is particularly relevant due to their Generally Recognized as Safe (GRAS) status, which enhances their applicability in food and health-related sectors compared to microbial EPS from other sources. Ultimately, this review contributes a critical synthesis that guides future research and industrial innovation, aligning with the growing demand for naturally derived, multifunctional, and health-promoting biopolymers.
Indexed as
Identifiers
41372575What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.